2 stories mentioning HKG:9996Updated just now
Every FINWIRES story that references HKG:9996, newest first.
Peijia Medical (HKG:9996) said Friday that Chinese health regulators have approved the registration of the company's GeminiOne system, a non-invasive transcatheter for heart complications, according to a same-day bourse filing.The company's GeminiOne is a proposed treatment for mitral regurgitation, a common form of valvular heart disease. Registration is currently underway in the EU, and an early feasibility study is ongoing in the U.S.
Peijia Medical (HKG:9996) subsidiary Achieva Medical entered into a distribution agreement with B. Braun Medical for the mainland China distribution of the SeQuent Please CIS paclitaxel drug-coated intracranial balloon dilatation catheter, according to a Monday Hong Kong bourse filing.The product is designed to treat intracranial vascular diseases and to deliver paclitaxel precisely to diseased blood vessel walls during balloon dilatation to reduce the risk of restenosis.
